| Primary |
| Asthma |
53.5% |
| Drug Use For Unknown Indication |
16.8% |
| Product Used For Unknown Indication |
8.4% |
| Hiv Infection |
5.1% |
| Bronchitis |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Asthmatic Crisis |
1.7% |
| Rhinitis |
1.0% |
| Viral Infection |
1.0% |
| Accidental Drug Intake By Child |
0.7% |
| Aphonia |
0.7% |
| Cough |
0.7% |
| Dyspnoea |
0.7% |
| Rales |
0.7% |
| Vomiting |
0.7% |
| Adrenal Insufficiency |
0.3% |
| Allergy Prophylaxis |
0.3% |
| Arthralgia |
0.3% |
| Arthritis |
0.3% |
| Atypical Pneumonia |
0.3% |
|
| Product Quality Issue |
10.0% |
| Asthmatic Crisis |
8.9% |
| Vomiting |
8.9% |
| Hypercorticoidism |
7.8% |
| Drug Ineffective |
5.6% |
| Tachycardia |
5.6% |
| Thrombocytosis |
5.6% |
| Adrenal Suppression |
4.4% |
| Asthma |
4.4% |
| Osteonecrosis |
4.4% |
| Pneumonia |
4.4% |
| Drug Administration Error |
3.3% |
| Ill-defined Disorder |
3.3% |
| Nightmare |
3.3% |
| Off Label Use |
3.3% |
| Rhinorrhoea |
3.3% |
| Treatment Noncompliance |
3.3% |
| Tremor |
3.3% |
| Visual Disturbance |
3.3% |
| Vitreous Detachment |
3.3% |
|
| Secondary |
| Asthma |
44.5% |
| Drug Use For Unknown Indication |
11.4% |
| Unevaluable Event |
8.9% |
| Product Used For Unknown Indication |
5.1% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
4.7% |
| Asthmatic Crisis |
3.4% |
| Hiv Infection |
3.4% |
| Bronchitis |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Allergic Bronchitis |
2.1% |
| Coronary Artery Disease |
1.7% |
| Infection Prophylaxis |
1.7% |
| Prophylaxis |
1.7% |
| Cardiovascular Disorder |
1.3% |
| Bronchopulmonary Aspergillosis |
0.8% |
| Depression |
0.8% |
| Dyspnoea |
0.8% |
| Polycythaemia Vera |
0.8% |
| Premature Menopause |
0.8% |
| Viral Infection |
0.8% |
|
| Weight Decreased |
14.8% |
| Pyrexia |
9.3% |
| Toe Amputation |
7.4% |
| White Blood Cell Count Increased |
7.4% |
| Product Quality Issue |
5.6% |
| Rhinorrhoea |
5.6% |
| Wheezing |
5.6% |
| Chest Pain |
3.7% |
| Cushing's Syndrome |
3.7% |
| Erythema Multiforme |
3.7% |
| Photosensitivity Reaction |
3.7% |
| Pneumonia |
3.7% |
| Skin Atrophy |
3.7% |
| Underdose |
3.7% |
| Upper Respiratory Tract Infection |
3.7% |
| Urinary Tract Infection Bacterial |
3.7% |
| Vomiting |
3.7% |
| Weight Increased |
3.7% |
| Adrenal Suppression |
1.9% |
| Allergic Granulomatous Angiitis |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.2% |
| Product Used For Unknown Indication |
17.2% |
| Asthma |
14.4% |
| Chronic Obstructive Pulmonary Disease |
9.1% |
| Rhabdomyosarcoma |
4.3% |
| Hypertension |
3.5% |
| Rheumatoid Arthritis |
2.9% |
| Epilepsy |
2.2% |
| Crohn's Disease |
2.1% |
| Atrial Fibrillation |
2.0% |
| Abdominal Pain |
1.6% |
| Pain |
1.6% |
| Prophylaxis |
1.3% |
| Angina Pectoris |
1.2% |
| Emphysema |
1.2% |
| Osteoporosis |
1.2% |
| Anaesthesia |
1.1% |
| Acne |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Premedication |
0.9% |
|
| Vomiting |
12.0% |
| Renal Failure Acute |
8.0% |
| Pneumonia |
7.2% |
| Drug Ineffective |
6.4% |
| Asthma |
5.6% |
| Pulmonary Embolism |
5.6% |
| Tremor |
5.6% |
| Dyspnoea |
4.8% |
| Mucosal Inflammation |
4.8% |
| Pharmaceutical Product Complaint |
4.8% |
| Wheezing |
4.8% |
| Prinzmetal Angina |
4.0% |
| Suicidal Ideation |
4.0% |
| Musculoskeletal Pain |
3.2% |
| Platelet Count Decreased |
3.2% |
| Product Taste Abnormal |
3.2% |
| Pupillary Reflex Impaired |
3.2% |
| Tendonitis |
3.2% |
| Thrombocytopenia |
3.2% |
| Transaminases Increased |
3.2% |
|
| Interacting |
| Asthma |
28.6% |
| Hiv Infection |
28.6% |
| Cough |
14.3% |
| Prophylaxis |
14.3% |
| Respiratory Tract Infection |
14.3% |
|
| Myalgia |
50.0% |
| Psychomotor Hyperactivity |
50.0% |
|
